News & events Upcoming events 120° Congresso Nazionale SIMI (Italian Society of Internal Medicine) Oct 18, 2019 - Oct 20, 2019 Rome , Italy More info and meet us there Belgian Week of Pathology 2019 Oct 18, 2019 - Oct 19, 2019 Brussels , Belgium More info and meet us there United European Gastroenterology week (UEGW) Oct 19, 2019 - Oct 23, 2019 Barcelona , Spain More info and meet us there See all upcoming events Latest news Morphotek®, Inc. Announces an Agreement With Fujirebio Diagnostics, Inc to commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab® Sep 5, 2017 Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it entered into a collaboration and license agreement with Fujirebio... Read more Fujirebio Europe announces the CE-marking of the Lumipulse® G Total Tau assay and extends its offer of fully automated assays aiding in the early diagnosis of Alzheimer’s disease Jul 16, 2017 Fujirebio Europe today announced the CE-marking of the Lumipulse G Total Tau assay for its fully automated LUMIPULSE immunoassay systems.... Read more Fujirebio Europe launches Lumipulse® G HTLV-I/II for fully automated screening of HTLV-I/II viral infection Apr 5, 2017 Fujirebio Europe today announced the release of Lumipulse G HTLV-I/II, a CE-marked CLEIA (chemiluminescent enzyme immunoassay) test kit for... Read more Fujirebio Europe launches the Lumipulse® G hs Troponin I and Lumipulse G Myoglobin immunoassays for both the LUMIPULSE G1200 and G600II platforms Mar 27, 2017 Fujirebio Europe has announced the release of the Lumipulse G hs Troponin I assay for use in the diagnosis of Acute Myocardial Infarction... Read more Fujirebio Europe launches Lumipulse® G β-Amyloid 1-42, a fully automated assay aiding in the early diagnosis of neurodegeneration Jan 23, 2017 Fujirebio Europe today announced the release of the Lumipulse G β-Amyloid 1-42 assay for its fully automated LUMIPULSE immunoassay systems.... Read more Welcome to Fujirebio Diagnostics customers! Jan 9, 2017 Since January 2nd 2017 Fujirebio Diagnostics AB (headquarters in Sweden) and Fujirebio Europe NV (headquarters in Belgium) share the same... Read more Load More
120° Congresso Nazionale SIMI (Italian Society of Internal Medicine) Oct 18, 2019 - Oct 20, 2019 Rome , Italy More info and meet us there
Belgian Week of Pathology 2019 Oct 18, 2019 - Oct 19, 2019 Brussels , Belgium More info and meet us there
United European Gastroenterology week (UEGW) Oct 19, 2019 - Oct 23, 2019 Barcelona , Spain More info and meet us there
Morphotek®, Inc. Announces an Agreement With Fujirebio Diagnostics, Inc to commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab® Sep 5, 2017 Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it entered into a collaboration and license agreement with Fujirebio... Read more
Fujirebio Europe announces the CE-marking of the Lumipulse® G Total Tau assay and extends its offer of fully automated assays aiding in the early diagnosis of Alzheimer’s disease Jul 16, 2017 Fujirebio Europe today announced the CE-marking of the Lumipulse G Total Tau assay for its fully automated LUMIPULSE immunoassay systems.... Read more
Fujirebio Europe launches Lumipulse® G HTLV-I/II for fully automated screening of HTLV-I/II viral infection Apr 5, 2017 Fujirebio Europe today announced the release of Lumipulse G HTLV-I/II, a CE-marked CLEIA (chemiluminescent enzyme immunoassay) test kit for... Read more
Fujirebio Europe launches the Lumipulse® G hs Troponin I and Lumipulse G Myoglobin immunoassays for both the LUMIPULSE G1200 and G600II platforms Mar 27, 2017 Fujirebio Europe has announced the release of the Lumipulse G hs Troponin I assay for use in the diagnosis of Acute Myocardial Infarction... Read more
Fujirebio Europe launches Lumipulse® G β-Amyloid 1-42, a fully automated assay aiding in the early diagnosis of neurodegeneration Jan 23, 2017 Fujirebio Europe today announced the release of the Lumipulse G β-Amyloid 1-42 assay for its fully automated LUMIPULSE immunoassay systems.... Read more
Welcome to Fujirebio Diagnostics customers! Jan 9, 2017 Since January 2nd 2017 Fujirebio Diagnostics AB (headquarters in Sweden) and Fujirebio Europe NV (headquarters in Belgium) share the same... Read more
